Taylor T N, Chrischilles E A
Division of Clinical and Administrative Pharmacy, College of Pharmacy, University of Iowa, Iowa City, USA.
Endocrinol Metab Clin North Am. 1997 Mar;26(1):67-87. doi: 10.1016/s0889-8529(05)70234-6.
This article provides a review of methods for conducting cost-effectiveness, cost-utility, and cost-benefit studies. Economic evaluations of interventions designed to improve outcomes of patients with diabetes and osteoporosis are reviewed, and key issues for future research are discussed. The role of cost-effectiveness analysis in reimbursement decision making at the public and private levels is explored.
